Generic Drug Industry in Spain Market Research & Statistics

24/7 Customer Support

Talk to Sam

+1 718 473 0872

All regions

You might be interested in: generics, biosimilars, drug, more »

5 reports

Download Unlimited Documents from Trusted Public Sources

Biosimilars Market Forecast in Europe

  • After Generics It's the Turn of Biosimilars, a Budding Market
  • September 2014
    2 pages
  • Biosimilars  

    Drug  

  • Europe  

    Spain  

    World  

View report >

Biosimilars Market Share in Europe - Forecast

  • Executive Summary
  • January 2014
    2 pages
  • Biosimilars  

  • Spain  

    Europe  

    Germany  

View report >

Global Generics Industry - Forecast

  • A Robust Generic Market: Difficulties and Complexities
  • March 2013
    23 pages
  • Generics  

  • Spain  

    World  

    Europe  

View report >

Generic Drug Markets in Spain

  • General Pharmaceutical Council of Spain - Villanueva, - - Madrid...
  • January 2013
  • Generic Drug  

    Internet Busine...  

    Fruit And Veget...  

  • Spain  

    Europe  

View report >

Generic Drug Markets - Forecast

  • To Browse this Report Kindly Visit
  • January 2011
    5 pages
  • Generic Drug  

    Generics  

  • United States  

    Europe  

View report >

Search in Generic Drug Industry

29 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 600 - $ 600)

Fesoterodine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Fesoterodine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

Frovatriptan - Patent, Extension And Data Exclusivity ...

October 2014 $ 653

Galantamine - Patent, Extension And Data Exclusivity E ...

October 2014 $ 653

Ibandronic Acid - Patent, Extension And Data Exclusivi ...

October 2014 $ 653

Imatinib - Patent, Extension And Data Exclusivity Expi ...

October 2014 $ 653

Lasofoxifene - Patent, Extension And Data Exclusivity ...

October 2014 $ 653

Pitavastatin - Patent, Extension And Data Exclusivity ...

October 2014 $ 653

Prasugrel - Patent, Extension And Data Exclusivity Exp ...

October 2014 $ 653

Rizatriptan - Patent, Extension And Data Exclusivity E ...

October 2014 $ 653

Valganciclovir - Patent, Extension And Data Exclusivit ...

October 2014 $ 653

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.